We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

11 hedge funds and large institutions have $798K invested in Yield10 Bioscience, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

10% more funds holding

Funds holding: 10 → 11 (+1)

33% less capital invested

Capital invested by funds: $1.19M → $798K (-$387K)

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Cannell & Co
New York
+$242K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$31.4K
3
TRCT
Tower Research Capital (TRC)
New York
+$11.2K
4
CWP
Concord Wealth Partners
Virginia
+$8.69K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$238

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$47K
2
Millennium Management
Millennium Management
New York
-$43.5K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$238
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Cannell & Co
New York
$427K +$242K +4,067 +61%
Vanguard Group
2
Vanguard Group
Pennsylvania
$173K +$238 +4 +0.1%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$58K -$238 -4 -0.3%
BlackRock
4
BlackRock
New York
$52.4K – – –
BC
5
Birchview Capital
Vermont
$31K – – –
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$20.9K +$31.4K +528 New
Millennium Management
7
Millennium Management
New York
$20K -$43.5K -730 -59%
TRCT
8
Tower Research Capital (TRC)
New York
$9K +$11.2K +188 +392%
CWP
9
Concord Wealth Partners
Virginia
$5.84K +$8.69K +146 New
IA
10
IFP Advisors
Florida
$1K – – –
Wells Fargo
11
Wells Fargo
California
$45 – – –
Bank of America
12
Bank of America
North Carolina
$14 – – –
UBS Group
13
UBS Group
Switzerland
$10 – – –
TWA
14
TCI Wealth Advisors
Arizona
$5 – – –
Morgan Stanley
15
Morgan Stanley
New York
$2 – – –
SIC
16
Salem Investment Counselors
North Carolina
$2 – – –
VF
17
Virtu Financial
New York
– -$47K -659 Closed

YTEN Hedge Fund Activity: Q4 2022 in Review

11 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2022, worth a combined $798K — down 33% from $1.19M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new YTEN positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Cannell & Co, adding an estimated $242K. The largest seller was Virtu Financial, exiting entirely with an estimated $47K sold.

  • 11 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2022, up from 10 in Q3 2022.
  • Funds reported $798K of Yield10 Bioscience, Inc. Common Stock stock for Q4 2022, down 33% quarter-over-quarter.
  • 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2022 and 1 closed out, a net change of +1 holder.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2022 was Cannell & Co, an estimated $242K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2022 was Virtu Financial, an estimated $47K sold.

Based on aggregated 13F filings for Q4 2022.